Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMRN | AMGN | VRTX | REGN | GSK |
| Company | Biomarin Pharmaceuticals | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 77.52 | 314.41 | 444.72 | 980.42 | 45.06 |
| High | 77.58 | 315.49 | 446.36 | 983.32 | 45.14 |
| Low | 76.56 | 312.92 | 442.99 | 978.21 | 44.95 |
| Last | 76.83 | 314.96 | 446.90 | 982.49 | 45.10 |
| Change | -0.73 | +2.49 | +1.69 | +0.20 | +0.12 |
| % Change | -0.94% | +0.80% | +0.38% | +0.02% | +0.27% |
| Volume | 130,528 | 185,840 | 68,762 | 39,097 | 215,610 |
| 20-Day Average Volume | 1,993,500 | 2,809,616 | 1,055,230 | 439,040 | 3,308,178 |
| Previous Close | 77.56 | 312.47 | 445.21 | 982.29 | 44.98 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 82.00 | 295.69 | 414.73 | 943.34 | 43.48 |
| 20-Day Raw Stochastic | 4.21% | 85.57% | 99.58% | 93.45% | 84.53% |
| 20-Day Relative Strength | 33.83% | 64.58% | 72.45% | 60.81% | 66.60% |
| Weighted Alpha | -17.67 | +42.31 | +36.24 | +34.38 | +35.14 |
| Today's Opinion | 100% Sell | 72% Buy | 72% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 100% Sell | 72% Buy | 72% Buy | 72% Buy | 100% Buy |
| Last Month's Opinion | 24% Sell | 56% Sell | 8% Buy | 24% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.53% since 05/13/24 | +1.93% since 05/13/24 | +3.77% since 05/13/24 | +0.47% since 05/13/24 | -0.15% since 05/13/24 |
| Low | 76.14 on 05/17/24 | 307.47 on 05/14/24 | 422.44 on 05/14/24 | 966.00 on 05/17/24 | 44.74 on 05/17/24 |
| High | 80.96 on 05/15/24 | 321.44 on 05/15/24 | 446.36 on 05/20/24 | 988.96 on 05/15/24 | 45.92 on 05/15/24 |
| 1-Month | |||||
| %Chg | -13.29% since 04/19/24 | +16.91% since 04/19/24 | +13.15% since 04/19/24 | +9.44% since 04/19/24 | +13.46% since 04/19/24 |
| Low | 76.14 on 05/17/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 39.96 on 04/22/24 |
| High | 93.01 on 04/24/24 | 322.60 on 05/03/24 | 446.36 on 05/20/24 | 988.96 on 05/15/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | -13.33% since 02/20/24 | +10.89% since 02/20/24 | +6.06% since 02/20/24 | +3.66% since 02/20/24 | +7.33% since 02/20/24 |
| Low | 76.14 on 05/17/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 94.15 on 02/23/24 | 322.60 on 05/03/24 | 446.36 on 05/20/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | -12.20% since 11/20/23 | +18.48% since 11/20/23 | +25.02% since 11/20/23 | +22.44% since 11/20/23 | +28.46% since 11/20/23 |
| Low | 76.14 on 05/17/24 | 260.52 on 11/21/23 | 346.29 on 11/28/23 | 792.57 on 11/28/23 | 35.13 on 11/22/23 |
| High | 99.56 on 12/14/23 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 14,727,092 | 167,619,840 | 114,887,776 | 108,234,592 | 93,218,352 |
| Shares Outstanding, K | 189,880 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 2,419,230,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | 167,650,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 648,830,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | 88,660,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | 0.34 | 0.60 | 0.39 | 0.17 | 0.65 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.71 on 04/24/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 04/24/24 | 05/02/24 | 05/06/24 | 05/02/24 | 05/01/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 57.01 | 16.89 | 29.26 | 26.08 | 11.11 |